Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1

Agriculture & Biology

• Human immunodeficiency virus 1 87%
• neutralizing antibodies 82%
• cytotoxicity 60%
• antibodies 46%
• mutants 41%
• complement 39%
• immunoglobulins 38%
• neutralization 16%
• point mutation 8%
• phagocytosis 8%
• virion 7%
• animal models 6%
• binding sites 6%
• mutation 5%
• viruses 5%
• cells 4%
• infection 4%

Medicine & Life Sciences

• Broadly Neutralizing Antibodies 100%
• HIV-1 61%
• Immunoglobulins 44%
• Antibodies 39%
• Complement C1q 30%
• Immunoglobulin Fc Fragments 14%
• Immunoglobulin Fragments 12%
• Antibody Affinity 12%
• Complement Activation 11%
• Neutralizing Antibodies 10%
• Phagocytosis 9%
• Point Mutation 9%
• Virion 9%
• Antiviral Agents 8%
• Binding Sites 7%
• Animal Models 7%
• Viruses 6%
• Mutation 5%
• Infections 4%
• In Vitro Techniques 4%